Human Immunodeficiency Virus  >>  Pegasys (pegylated interferon α -2a)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pegasys (pegylated interferon α -2a) / Roche
NCT00611819 / 2005-000203-34: Two Different Treatments 24 vs 48 Weeks Chronic Hepatitis C Genotypes 2 and/or 3 in co-Infected HIV-HCV

Unknown status
4
59
Europe
Peg interferon + Ribavirin, Pegasys
University of Valencia, Hoffmann-La Roche
Chronic Hepatitis C, Co-Infection HIV-HCV
04/08
12/08
NCT02761629: Efficacy and Safety of Peg-Interferon Alpha-2a Plus Ribavirin in Genotype 1 Chronic Hepatitis C Participants Co-Infected With Human Immunodeficiency Virus

Completed
4
180
RoW
Peg-Interferon Alpha-2A, Pegasys, Peg-IFN-Alpha-2A, Ribavirin
Hoffmann-La Roche
Hepatitis C, Chronic
05/08
05/08
NCT00353418 / 2005-005506-23: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection

Completed
4
415
US
Peginterferon alfa-2a, Pegasys, Ribavirin, Copegus
Hoffmann-La Roche
Hepatitis C, Chronic
04/09
04/09

Download Options